AI Decodes Gut Bacteria to Unlock New Health Insights

Tokyo — In a groundbreaking study, researchers at the University of Tokyo have used a specialised form of artificial intelligence (AI), known as a Bayesian neural network, to analyse gut bacteria in ways that existing tools have struggled to achieve.

Gut bacteria play a crucial role in human health. While the human body contains around 30 to 40 trillion cells, the intestines alone house approximately 100 trillion gut bacteria.

“The real challenge is that we’re still at the early stages of understanding which bacteria produce which human metabolites, and how these relationships shift during different diseases,” explained Project Researcher Tung Dang from the Tsunoda Lab, Department of Biological Sciences. The study was recently published in Briefings in Bioinformatics.

Dang believes that by accurately mapping the links between gut bacteria and human metabolites, personalised treatments for a wide range of health issues could become a reality. “Imagine cultivating specific bacteria to produce beneficial metabolites, or developing precise therapies to modify these chemicals to help treat diseases,” Dang added.

The AI system, called VBayesMM, is designed to automatically identify the key bacterial groups that have a significant impact on metabolite production. Unlike conventional tools, VBayesMM accounts for uncertainties in the data, avoiding overly confident but potentially incorrect conclusions.

“When we tested our system on real-world data from studies on sleep disorders, obesity, and cancer, it consistently outperformed traditional methods,” Dang stated. “It identified specific bacterial families that align with known biological processes, suggesting that our system uncovers genuine biological connections, rather than random statistical noise.”

One of the system’s key strengths is its ability to handle uncertainty, giving researchers greater confidence in its predictions. While VBayesMM is built to manage large, complex datasets, analysing such vast amounts of information still comes with significant computational demands — though these are expected to decrease over time.

Looking ahead, Dang and the team plan to apply their approach to more extensive chemical datasets to capture the full range of products generated by gut bacteria. However, this introduces new challenges, such as distinguishing between chemicals originating from bacteria, the human body, or external factors like diet.

With inputs from IANS